ANI Pharmaceuticals, Inc.
Price Action
Technical Summary
CONSOLIDATINGANI Pharmaceuticals, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 55), indicating performance broadly in line with the market. Earnings growth of 86% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $82.40 | +3.22% | ABOVE |
| 50 SMA | $81.00 | +5.01% | ABOVE |
| 100 SMA | $78.66 | +8.12% | ABOVE |
| 150 SMA | $79.71 | +6.70% | ABOVE |
| 200 SMA | $82.38 | +3.24% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ANIP in an uptrend right now?
ANIP has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is ANIP overbought or oversold?
ANIP's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is ANIP outperforming the market?
ANIP has a Relative Strength (RS) Rating of 55 out of 99. ANIP is performing about average compared to the market.
Where is ANIP in its 52-week range?
ANIP is trading at $85.05, which is 85% of its 52-week high ($99.50) and 61% above its 52-week low ($62.61).
How volatile is ANIP?
ANIP has a Beta of 0.49 and 52-week volatility of 36%. It's less volatile than the S&P 500 - generally more stable.